Skip to main content

Table 1 Clinical and pathological characteristics of patients with DLBCL in our study

From: Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma

Characteristics

Discovery cohort

Internal validation cohort

GSE31312 cohort

GSE10846 cohort

GSE4475 cohort

No. of patients

213

213

426

350

129

Age, year

 >60

121

123

244

196

72

 ≤60

92

90

182

154

57

Gender

 Female

101

82

183

152

54

 Male

112

131

243

184

74

 Unknown

14

1

Stage

 I/II

97

106

203

160

36

 III/IV

116

107

223

184

48

 Unknown

6

45

No. of extranodal sites

 <2

167

170

337

299

 

 ≥2

46

43

89

26

 Unknown

25

LDH

 0

72

61

133

140

1

120

133

253

156

Unknown

21

19

40

54

ECOG

 <2

168

171

339

256

 

 ≥2

45

42

87

74

Unknown

20

Subtype

 GCB

106

121

227

183

74

 ABC

107

92

199

167

55

Unclassified

Survival status

Dead

80

74

154

143

51

Alive

133

139

272

207

42

Unknown

36